THE ENVELOPE OF MYCOBACTERIA

被引:1497
作者
BRENNAN, PJ [1 ]
NIKAIDO, H [1 ]
机构
[1] UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA
关键词
CELL WALL; ARABINOGALACTAN; MYCOLIC ACID; PERMEABILITY BARRIER; DRUG RESISTANCE;
D O I
10.1146/annurev.bi.64.070195.000333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycobacteria, members of which cause tuberculosis and leprosy, produce cell walls of unusually low permeability, which contribute to their resistance to therapeutic agents. Their cell walls contain large amounts of C-60-C-90 fatty acids, mycolic acids, that are covalently linked to arabinogalactan. Recent studies clarified the unusual structures of arabinogalactan as well as of extractable cell wall lipids, such as trehalose-based lipooligosaccharides, phenolic glycolipids, and glycopeptidolipids. Most of the hydrocarbon chains of these lipids assemble to produce an asymmetric bilayer of exceptional thickness. Structural considerations suggest that the fluidity is exceptionally low in the innermost part of bilayer, gradually increasing toward the outer surface. Differences in mycolic acid structure may affect the fluidity and permeability of the bilayer, and may explain the different sensitivity levels of various mycobacterial species to lipophilic inhibitors. Hydrophilic nutrients and inhibitors, in contrast, traverse the cell wall presumably through channels of recently discovered porins.
引用
收藏
页码:29 / 63
页数:35
相关论文
共 153 条
[51]   STUDIES ON STRUCTURE AND BIOSYNTHESIS OF SPECIFIC GLYCOLIPIDS ISOLATED FROM MYCOBACTERIA - MYCOSIDES-A AND MYCOSIDES-B [J].
GASTAMBI.M ;
SARDA, P .
PNEUMONOLOGIE-PNEUMONOLOGY, 1970, 142 (2-4) :241-&
[52]   BIOSYNTHESE DE LACIDE C32-MYCOCEROSIQUE INCORPORATION DACIDE PROPIONIQUE [J].
GASTAMBIDEODIER, M ;
DELAUMENY, JM ;
LEDERER, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1963, 70 (06) :670-&
[53]  
GASTAMBIDEODIER M, 1963, CHEM IND-LONDON, P1285
[54]  
GAYLORD H, 1987, ANNU REV MICROBIOL, V41, P645
[55]   ACTIVITY OF MINOCYCLINE IN MYCOBACTERIUM-LEPRAE INFECTED MICE [J].
GELBER, RH .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01) :236-239
[57]  
GOLDMAN DS, 1970, AM REV RESPIR DIS, V102, P543
[58]  
Goren M.B., 1979, TUBERCULOSIS, P63
[59]   COMPARATIVE ANTIMYCOBACTERIAL ACTIVITIES OF DIFLOXACIN, TEMAFLOXACIN, ENOXACIN, PEFLOXACIN, REFERENCE FLUOROQUINOLONES, AND A NEW MACROLIDE, CLARITHROMYCIN [J].
GORZYNSKI, EA ;
GUTMAN, SI ;
ALLEN, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) :591-592
[60]   INFLUENCE OF N SUBSTITUTION ON ANTIMYCOBACTERIAL ACTIVITY OF CIPROFLOXACIN [J].
HAEMERS, A ;
LEYSEN, DC ;
BOLLAERT, W ;
ZHANG, MQ ;
PATTYN, SR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :496-497